Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Larger Nutritional Studies Needed To Fill Data Gap – HHS Panel

This article was originally published in The Tan Sheet

Executive Summary

USPSTF recommends expanded research and innovative methods to explore the effects and complexities of nutrients. The panel says current research is insufficient to determine whether the use of multivitamins and single-ingredient dietary supplements help prevent CVD or cancer, and recommends against the use of beta-carotene or vitamin E supplements for prevention of the conditions.

You may also be interested in...



Supplement Trade Groups Focus On GMP Compliance, R&D in 2014

Dietary supplement industry trade groups’ 2014 goals include improving GMP compliance, defining “natural” and advancing research in the supplement space. Stakeholders await revised guidances on NDI notifications and on distinguishing liquid supplements from traditional beverages.

Supplement Trade Groups Focus On GMP Compliance, R&D in 2014

Dietary supplement industry trade groups’ 2014 goals include improving GMP compliance, defining “natural” and advancing research in the supplement space. Stakeholders await revised guidances on NDI notifications and on distinguishing liquid supplements from traditional beverages.

HHS Supplement Report Conclusions Need Revision, Trade Groups Say

Recent draft guidance issued by the USPSTF has supplement industry groups calling for revisions that will reflect a more positive light on nutritional ingredients and that won’t be misinterpreted by consumers.

Related Content

Topics

UsernamePublicRestriction

Register

LL009864

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel